Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

3.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.5K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

3.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.2K
Anorexia Nervosa01:28

Anorexia Nervosa

274
Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
274
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

2.0K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.0K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

12.6K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
12.6K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

536
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
536

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Obesity and Heart Failure: Introducing the Theme.

Journal of cardiovascular development and disease·2026
Same author

Targeting the activin/myostatin - actrii pathway to preserve skeletal muscle mass in obesity: mechanistic insights and therapeutic perspectives.

Reviews in endocrine & metabolic disorders·2026
Same author

Leptin/Adiponectin Ratio as a new multidimensional biomarker in obese patients with liver steatosis undergoing VLEKT: results from a pilot study.

Frontiers in nutrition·2026
Same author

Autotaxin and Lysophosphatidic Acid Circulating Levels Correlate with Body Mass Index in Obese Subjects with MASLD.

International journal of molecular sciences·2026
Same author

A Dose-Response Study on the Relationship Between Red Meat Intake and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Southern Italy: Results from the Nutrihep Study.

Nutrients·2026
Same author

Effects of a Bioactive Vegetable-Enriched Diet on Autotaxin and Liver Fibrosis in MASLD with Evidence of Sex-Specific Responses: A Pilot Study.

Nutrients·2025

Related Experiment Video

Updated: Oct 14, 2025

A Computer-Based Platform for Aiding Clinicians in Eating Disorder Analysis and Diagnosis
04:19

A Computer-Based Platform for Aiding Clinicians in Eating Disorder Analysis and Diagnosis

Published on: May 10, 2022

4.0K

Eating Disorders and Type 1 Diabetes: A Perspective.

Simonetta Marucci1, Giulia De Iaco1, Giuseppe Lisco2

  • 1Dip. "Scienze e Tecnologie per l'Uomo e l'ambiente", Università Campus Biomedico", Via Alvaro del Portillo 21, Roma, Italy.

Endocrine, Metabolic & Immune Disorders Drug Targets
|November 9, 2021
PubMed
Summary

Type 1 diabetes patients face higher risks of eating disorders (EDs) and disordered eating behaviors (DEBs). Early detection and management are crucial for better outcomes in this vulnerable population.

Keywords:
Type 1 diabetes mellitusanorexia nervosabinge eating disordersbulimiadisordered eating behaviorseating disorders

More Related Videos

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.9K
Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms
08:16

Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms

Published on: March 15, 2024

1.7K

Related Experiment Videos

Last Updated: Oct 14, 2025

A Computer-Based Platform for Aiding Clinicians in Eating Disorder Analysis and Diagnosis
04:19

A Computer-Based Platform for Aiding Clinicians in Eating Disorder Analysis and Diagnosis

Published on: May 10, 2022

4.0K
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.9K
Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms
08:16

Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms

Published on: March 15, 2024

1.7K

Area of Science:

  • Endocrinology
  • Psychiatry
  • Public Health

Background:

  • Type 1 diabetes (T1D) patients exhibit increased prevalence of eating disorders (EDs) and disordered eating behaviors (DEBs) compared to the general population.
  • These issues are often linked to the physical and psychosocial challenges inherent in managing T1D, frequently emerging in childhood.
  • Disordered eating behaviors (DEBs) in T1D can escalate to severe clinical EDs, significantly worsening patient prognosis.

Purpose of the Study:

  • To review the current scientific literature on the relationship between T1D and DEBs/EDs.
  • To highlight the epidemiological and clinical complexity of these co-occurring conditions.
  • To provide a concise overview of management strategies for DEBs in T1D patients.

Main Methods:

  • Systematic review of scientific articles.
  • Analysis of epidemiological data.
  • Synthesis of clinical findings and management approaches.

Main Results:

  • Confirmed elevated risk of EDs and DEBs in T1D patients.
  • Identified diabetes-specific physical and psychosocial factors contributing to DEBs.
  • Highlighted the diagnostic and therapeutic challenges associated with T1D and EDs/DEBs.

Conclusions:

  • DEBs and EDs represent a significant, complex comorbidity in T1D.
  • Prompt investigation and management of DEBs are essential to prevent progression to severe EDs and improve patient outcomes.
  • Further research is needed to refine diagnostic and treatment strategies for this population.